A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases
Clinical trial NCT07265206 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07265206
- Sponsor
- Juventas Cell Therapy Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2026-12-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.